SFRP1, Recombinant, Human (Secreted Frizzled Related Protein 1, SARP2, FrzA) (BSA Free)

Produktübersicht

• Artikelname: SFRP1, Recombinant, Human (Secreted Frizzled Related Protein 1, SARP2, FrzA) (BSA Free)
• Artikelnummer: USB-S1012-86RX
• Hersteller Artikelnummer: S1012-86RX
• Alternativnummer: USB-S1012-86RX-25
• Hersteller: US Biological
• Kategorie: Molekularbiologie

Produktbeschreibung

Secreted Frizzled Related Proteins (sFRPs) are a family of secreted, soluble vertebrate glycoproteins which contain homology to the Wnt-binding domain of the Frizzled (Fz) family of transmembrane receptors. sFRPs are approximately 30-35kD in size and are comprised of 3 domains: a signal sequence, an N-terminal Fz cysteine-rich domain (CRD) with 10 conserved cysteines, and a C-terminal heparin-binding region with weak homology to Netrin. The Fz CRD mediates Wnt-binding and is present in all Fz and sFRP family members (1). sFRP-1, also known as secreted apoptosis-related protein 2 (SARP-2), FRP and FrzA, is expressed in the embryonic kidney, eye, brain, teeth, salivary gland and small intestine, most often at sites of epithelial-mesenchyme interaction (5). Expression in the adult animal is strong in the eye, kidney, and heart and also prevalent in the brain and lung (2,5). sFRP-1 was first characterized as a protein that enhances the sensitivity of cells to apoptotic stimuli (3) and as an antagonist of Wnt signaling in Xenopus embryos (4). It is also characterized as a tumor suppressor in breast (6) and cervical carcinomas (7). In contrast, sFRP-1 is expressed by the majority of malignant gliomas (8) and contributes to the development of uterine leiomyomas (9) suggesting that the role of sFRP-1 is dependent on cell context. sFRP-1 has diverse activities, from inducing angiogenesis (10) in a variety of in vivo models to helping regulate Wnt-4 signaling (with sFRP-2) in renal organogenesis (11) Mouse and human sFRP-1 proteins share 94% amino acid identity (1). Activity: Measured by its ability to inhibit proliferation of human HUH-7 hepatocellular carcinoma cells. The ED50 for this effect is typically 2.5-10ug/ml. Storage and Stability: Lyophilized powder may be stored at -20C. Reconstitute to nominal volume by adding sterile buffer. Aliquot and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Produkteigenschaften

• Reinheit: 95%, as determined by SDS-PAGE and visualized by silver stain. Endotoxin: 1EU/ug (LAL)
• Formulierung: Supplied as a lyophilized powder in PBS, pH 7.0. Reconstitute with sterile PBS to 50ug/ml. For long term storage as a dilute solution, a carrier protein (e.g. 0.1% HSA or BSA) should be added to the vial.